BAC
Bank of America Corporation
BAC has the edge over HWC overall, supported by stronger fundamentals and stronger valuation.
HWC
Hancock Whitney Corporation
HWC's outlook is improving, though it still trails on the overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
HWC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
HWC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like HWC.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over HWC in the historical PE scenario, which offers more potential upside but is not a forecast.
HWC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.1x | $40.37 | -38% |
| Forward | 9.2x | $65.00 | — |
| Fair | 10x | $52.07 | -20% |
| Expensive | 13x | $64.92 | -0.1% |
| Current | 13x | $65.00 | — |
Historical ranges are pointers, not guarantees.
HWC's PE is in its expensive range at 13x. If earnings grow as analysts expect, today's price would be 9.2x next year's earnings, in its cheap range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
HWC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for HWC, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over HWC on earnings, with more consistent year-over-year improvement.
HWC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.08 | +43% |
| Q3 2026 | $4.96 | -11% |
| Q2 2026 | $5.09 | -6.3% |
| Q1 2026 | $4.86 | -10% |
| Q4 2025 | $5.67 | +7.4% |
| Q3 2025 | $5.59 | +25% |
| Q2 2025 | $5.43 | +28% |
| Q1 2025 | $5.42 | +26% |
| Q4 2024 | $5.28 | +17% |
HWC earned $4.96 per share over the past year, down 11% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over HWC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
HWC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $420.1M | +8.9% |
| Q2 2026 | $401.4M | +6.9% |
| Q1 2026 | $292.6M | -20% |
| Q4 2025 | $389.3M | +6.7% |
| Q3 2025 | $385.7M | +4.9% |
| Q2 2025 | $375.5M | +4.4% |
| Q1 2025 | $364.7M | +3% |
| Q4 2024 | $364.8M | +18% |
HWC's revenue grew through 2024 and has held roughly level since: $420M last quarter, up 8.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -7.8 points |
| Q2 2026 | 40% | +1.9 points |
| Q1 2026 | 20% | -21 points |
| Q4 2025 | 41% | -0.6 points |
| Q3 2025 | 42% | +2.1 points |
| Q2 2025 | 39% | -1.8 points |
| Q1 2025 | 41% | +3.2 points |
| Q4 2024 | 41% | +21 points |
HWC has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
HWC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $255M | +65% |
| Q2 2026 | $150.4M | +23% |
| Q1 2026 | $108.4M | +8.2% |
| Q4 2025 | $145.9M | -23% |
| Q3 2025 | $155M | -2.3% |
| Q2 2025 | $122M | +18% |
| Q1 2025 | $100.2M | -39% |
| Q4 2024 | $188.8M | +104% |
HWC has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has 7.2B diluted shares, down 5.3% from a year ago, with $25.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
HWC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.1% | -873K shares |
| 1 year | -5.7% | -4.8M shares |
| 3 years | -6.7% | -5.8M shares |
| 5 years | -7.3% | -6.4M shares |
| Available history | -6.9% | -6M shares |
HWC has the edge over BAC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $82.4M |
| Q2 2026 | $46.5M |
| Q1 2026 | $94.6M |
| Q4 2025 | $146.6M |
| Q3 2025 | $40.1M |
| Q2 2025 | $39.4M |
| Q1 2025 | $20.7M |
| Q4 2024 | $7.9M |
HWC spent $370M buying back its own shares over the past year, about three times what it spent the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
HWC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 2.1x | Moderate |
| Q1 2026 | 1.8x | Healthy |
| Q4 2025 | 1.0x | Healthy |
| Q3 2025 | 2.5x | Moderate |
| Q2 2025 | 1.2x | Healthy |
| Q1 2025 | 0.4x | Very low |
| Q4 2024 | 0.5x | Very low |
HWC has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
HWC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.0 | Neutral |
| Stochastic | 31.9 | Neutral |
HWC's weekly RSI is 34 (neutral) and its Stochastic is 32 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over HWC on valuation relative to its sector.
HWC PE vs Financial Services Sector
| Metric | HWC | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.6% above |
| PE % | 83 | 63 | 20 pts above |
HWC is trading at 13x earnings, in line with the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
HWC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $71.8 | 9.5% below |
| 20 week MA | $74.5 | 13% below |
| 50 week MA | $70.1 | 7.3% below |
| 100 week MA | $63.6 | 2.2% above |
| 200 week MA | $54.3 | 20% above |
HWC has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
HWC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $43.8 | $34.2 | -22% |
| 2021 | $34.2 | $48.6 | +42% |
| 2022 | $48.6 | $48.5 | -0.3% |
| 2023 | $48.5 | $48.6 | +0.2% |
| 2024 | $48.6 | $54.9 | +13% |
| 2025 | $54.9 | $65.2 | +19% |
| 2026 YTD | $65.2 | $65.0 | -0.3% |
HWC has the edge over BAC on returns for 2026, with the stronger performance.